Fibrosis in Hepatitis C Patients Predicts Complications After Elective Total Joint Arthroplasty


      Effects of Hepatitis C on total hip (THA) and total knee arthroplasty (TKA) outcomes are poorly understood. Seventy-two hepatitis C patients underwent 77 primary THA or TKA and were retrospectively identified, stratified by fibrosis and thrombocytopenia and compared to matched controls. Overall, Hepatitis C and control patients had similar outcomes. After TKA, fibrotic hepatitis C patients demonstrated a greater average hemoglobin drop than non-fibrotic hepatitis C patients (4.9 versus 3.8, P = 0.023), greater deep infection rate (21% versus 0%, P = 0.047), and rate of cellulitis (21% versus 0%, P = 0.047). Thrombocytopenia showed a trend toward greater infections. Prior to fibrosis, Hepatitis C patients appear to be at no increased risk of complication after joint arthroplasty. Evaluation of fibrosis may predict poor outcome in Hepatitis C patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ghany M.G.
        • Strader D.B.
        • Thomas D.L.
        • et al.
        AASLD Practice Guidelines: Diagnosis, management, and treatment of hepatitis C: An update.
        Hepatology. 2009; 49: 1335
        • Villani C.
        • Conte S.
        • Chiozzi F.
        • et al.
        Prevalence of hepatitis B and hepatitis C in an orthopedics and traumatology ward.
        Chir Organi Mov. 2001; 86: 167
        • Rosen H.R.
        Chronic Hepatitis C Infection.
        N Engl J Med. 2011; 364: 2429
        • Smith J.O.
        • Sterling R.K.
        Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C.
        Aliment Pharmacol Ther. 2009; 30: 557
        • Cohen S.M.
        • Te HS Levitsky J.
        Operative risk of total hip and knee arthroplasty in cirrhotic patients.
        J Arthroplasty. 2005; 20: 460
        • Shih L.Y.
        • Cheng C.Y.
        • Chang C.H.
        • et al.
        Total knee arthroplasty in patients with liver cirrhosis.
        J Bone Joint Surg Am. 2004; 86: 335
        • Suman A.
        • Carey W.
        Assessing the risk of surgery in patients with liver disease.
        Cleve Clin J Med. 2006; 73: 398
        • Friedman L.
        The risk of surgery in patients with liver disease.
        Hepatology. 1999; 29: 1617
        • Pour A.E.
        • Matar W.Y.
        • Jafari S.M.
        • et al.
        Total joint arthroplasty in patients with hepatitis C.
        J Bone Joint Surg Am. 2011; 93: 1448
        • Olariu M.
        • Olariu C.
        • Olteanu D.
        Thrombocytopenia in chronic hepatitis C.
        J Gastrointestin Liver Dis. 2010; 19: 381
        • Louie K.S.
        • Micallef J.M.
        • Pimenta J.M.
        • et al.
        Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.
        J Viral Hepat. 2011; 18: 1
        • Smith B.
        • et al.
        Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945–1965.
        Morb Mortal Wkly Rep. 2012; 61: 1
        • Carole B.
        • Cheung R.
        • Giori N.
        Prevalence of hepatitis C virus infection in the veteran population undergoing total joint arthroplasty.
        J Arthroplasty. 2012; 27: 1772
        • Smyth S.
        • et al.
        Platelet functions beyond hemostasis.
        J Thromb Hemost. 2009; 7: 1759
        • Hsieh P.
        • et al.
        Hip arthroplasty in patients with cirrhosis of the liver.
        J Bone Joint Surg. 2003; 85: 818
        • Hsieh P.
        • et al.
        Prosthetic hip infection in patients with hip cirrhosis: an outcome analysis.
        Int J Infect Dis. 2010; 14: e1054
        • Moon Y.
        • et al.
        Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease.
        J Korean Med Sci. 2007; 22: 223